Researchers developed a deep learning-driven MASLD classification system for precision risk management.
Key Details
- 1Study analyzed 1,111 liver biopsies to train a deep LASSO model using six clinical indicators.
- 2Algorithm defined four MASLD subtypes with distinct risk profiles for hepatic and extrahepatic complications.
- 3External validation performed in cohorts of 6,172 and 7,406 adults; clustering was consistent.
- 4Cluster 4 displayed highest risk for combined cardiovascular, liver, and kidney complications, and high frequency of PNPLA3 risk alleles.
- 5The classification intends to tailor interventions, such as prioritizing fibrosis screening or cardiorenal protection, by subtype.
Why It Matters
The use of advanced AI/machine learning in clinical stratification sets a precedent for data-driven, precision approaches in metabolic and cardiometabolic disease management. Implications exist for integration with imaging biomarkers and improving targeted clinical decision-making in radiology and hepatology.
Source
EurekAlert
Related News
•EurekAlert
New AI Method Removes Artifacts in Super-Resolution Fluorescence Microscopy
Researchers unveil Adaptive-SN2N, a self-supervised deep learning framework that suppresses background artifacts in super-resolution fluorescence microscopy images.
•EurekAlert
Micro-CT and AI Reveal Hidden Damage in Coral Skeletons
Researchers combined micro-CT imaging and deep learning to detect subtle disease-induced changes in coral skeletons with high accuracy.
•EurekAlert
Deep Learning AI Deciphers Hidden Self-Organization in Bacterial Colonies
Rice University researchers engineered an AI system to reveal subtle organizational patterns in bacterial communities using time-lapse microscopy data.